110 related articles for article (PubMed ID: 23095029)
21. Alteration of human leukotriene A4 hydrolase activity after site-directed mutagenesis: serine-415 is a regulatory residue.
Rybina IV; Feinmark SJ
Biochim Biophys Acta; 1999 May; 1438(2):199-203. PubMed ID: 10320802
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
[TBL] [Abstract][Full Text] [Related]
23. The development of novel LTA
Low CM; Akthar S; Patel DF; Löser S; Wong CT; Jackson PL; Blalock JE; Hare SA; Lloyd CM; Snelgrove RJ
Sci Rep; 2017 Mar; 7():44449. PubMed ID: 28303931
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation.
Thunnissen MM; Nordlund P; Haeggström JZ
Nat Struct Biol; 2001 Feb; 8(2):131-5. PubMed ID: 11175901
[TBL] [Abstract][Full Text] [Related]
25. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.
Snelgrove RJ; Jackson PL; Hardison MT; Noerager BD; Kinloch A; Gaggar A; Shastry S; Rowe SM; Shim YM; Hussell T; Blalock JE
Science; 2010 Oct; 330(6000):90-4. PubMed ID: 20813919
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.
Oi N; Jeong CH; Nadas J; Cho YY; Pugliese A; Bode AM; Dong Z
Cancer Res; 2010 Dec; 70(23):9755-64. PubMed ID: 20952510
[TBL] [Abstract][Full Text] [Related]
28. Azabenzthiazole inhibitors of leukotriene A₄ hydrolase.
Tanis VM; Bacani GM; Blevitt JM; Chrovian CC; Crawford S; De Leon A; Fourie AM; Gomez L; Grice CA; Herman K; Kearney AM; Landry-Bayle AM; Lee-Dutra A; Nelson J; Riley JP; Santillán A; Wiener JJ; Xue X; Young AL
Bioorg Med Chem Lett; 2012 Dec; 22(24):7504-11. PubMed ID: 23127888
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design.
Thangapandian S; John S; Arooj M; Lee KW
PLoS One; 2012; 7(4):e34593. PubMed ID: 22496831
[TBL] [Abstract][Full Text] [Related]
30. Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
Davies DR; Mamat B; Magnusson OT; Christensen J; Haraldsson MH; Mishra R; Pease B; Hansen E; Singh J; Zembower D; Kim H; Kiselyov AS; Burgin AB; Gurney ME; Stewart LJ
J Med Chem; 2009 Aug; 52(15):4694-715. PubMed ID: 19618939
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, docking, cytotoxicity, and LTA
El-Naggar MH; Mira A; Abdel Bar FM; Shimizu K; Amer MM; Badria FA
Bioorg Med Chem; 2017 Feb; 25(3):1277-1285. PubMed ID: 28065501
[TBL] [Abstract][Full Text] [Related]
32. Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness.
Rao NL; Riley JP; Banie H; Xue X; Sun B; Crawford S; Lundeen KA; Yu F; Karlsson L; Fourie AM; Dunford PJ
Am J Respir Crit Care Med; 2010 May; 181(9):899-907. PubMed ID: 20110560
[TBL] [Abstract][Full Text] [Related]
33. A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.
Poras H; Duquesnoy S; Fournié-Zaluski MC; Ratinaud-Giraud C; Roques BP; Ouimet T
Anal Biochem; 2013 Oct; 441(2):152-61. PubMed ID: 23851339
[TBL] [Abstract][Full Text] [Related]
34. Effect of alpha lipoic acid on leukotriene A
Torres MJ; Fierro A; Pessoa-Mahana CD; Romero-Parra J; Cabrera G; Faúndez M
Eur J Pharmacol; 2017 Mar; 799():41-47. PubMed ID: 28132911
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal regulation of LTA(4) hydrolase expression in human monocytes by gamma-interferon and interleukins 4 and 13: potential relevance to leukotriene regulation in glomerular disease.
Montero A; Nassar GM; Uda S; Munger KA; Badr KF
Exp Nephrol; 2000; 8(4-5):258-65. PubMed ID: 10940725
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.
Thunnissen MM; Andersson B; Samuelsson B; Wong CH; Haeggström J
FASEB J; 2002 Oct; 16(12):1648-50. PubMed ID: 12207002
[TBL] [Abstract][Full Text] [Related]
37. Regulation of leukotriene A4 hydrolase activity in endothelial cells by phosphorylation.
Rybina IV; Liu H; Gor Y; Feinmark SJ
J Biol Chem; 1997 Dec; 272(50):31865-71. PubMed ID: 9395533
[TBL] [Abstract][Full Text] [Related]
38. Leukotriene A(4)-hydrolase expression and leukotriene B(4) levels in chronic inflammation of bacterial origin: immunohistochemistry and reverse-phase high-performance liquid chromatography analysis of oral mucosal epithelium.
Eberhard J; Jepsen S; Tiemann M; Krause R; Açil Y; Albers HK
Virchows Arch; 2002 Jun; 440(6):627-34. PubMed ID: 12070603
[TBL] [Abstract][Full Text] [Related]
39. Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase.
Thangapandian S; John S; Sakkiah S; Lee KW
J Chem Inf Model; 2011 Jan; 51(1):33-44. PubMed ID: 21133343
[TBL] [Abstract][Full Text] [Related]
40. Capturing LTA
Stsiapanava A; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9689-9694. PubMed ID: 28827365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
